Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
KDMF
0
VMF
0
Europe
0
Australia
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Ephedrine
2. Ephedrine Erythro Isomer
3. Ephedrine Hydrochloride
4. Ephedrine Renaudin
5. Erythro Isomer Of Ephedrine
6. Hydrochloride, Ephedrine
7. Renaudin, Ephedrine
8. Sal Phedrine
9. Sal-phedrine
10. Salphedrine
11. Sulfate, Ephedrine
1. Ephedrine Sulphate
2. Isofedrol
3. Akovaz
4. 134-72-5
5. Corphedra
6. Ephedrine Sulfate [usp]
7. U6x61u5zeg
8. (-)-ephedrine Sulfate (2:1) (salt)
9. 134-72-5 (sulfate)
10. (-)-ephedrine Hemisulfate
11. Nci-c55652
12. Ephedrine Sulfate (usp)
13. Benzenemethanol, Alpha-((1s)-1-(methylamino)ethyl)-, (alphar)-, Sulfate (2:1) (salt)
14. (1r,2s)-2-(methylamino)-1-phenylpropan-1-ol;sulfuric Acid
15. L-ephedrine Sulfate
16. Unii-u6x61u5zeg
17. Expansyl
18. Ccris 1351
19. Ephedrini Sulfas
20. Pazo Ointment
21. Franol Plus
22. Franol-plus
23. (1r,2s)-2-(methylamino)-1-phenylpropan-1-ol Sulfate (2:1) (salt)
24. Pazo Suppositories
25. Corphedra (tn)
26. Emerphed (tn)
27. Einecs 205-154-4
28. Akovaz (tn)
29. Emerphed
30. Ephedrine L- Sulfate
31. 1-phenyl-2-methylamine-propanol-1-sulfate
32. Ec 205-154-4
33. Schembl41262
34. (1r,2s)-1-phenyl-2-methylaminopropanol-1 Sulfate
35. Ephedrine Sulfate [mi]
36. 1-alpha-(1-(methylamino)ethyl)benzyl Alcohol Sulfate
37. Chembl1523964
38. Dtxsid6020565
39. Ephedrine Sulfate [vandf]
40. Ephedrine Sulfate [mart.]
41. Ephedrine Sulfate [usp-rs]
42. Ephedrine Sulfate [who-dd]
43. Ephedrine Sulfate [who-ip]
44. (-)-erythro-1-hydroxy-2-(methylamino)-1-phenylpropane Sulfate
45. Bdbm50480314
46. Akos015901652
47. Ephedrine Sulfate [orange Book]
48. Ephedrini Sulfas [who-ip Latin]
49. Ephedrine Sulfate [usp Monograph]
50. Ncgc00093901-01
51. Ephedrine Sulfate (2:1) (salt), (-)-
52. Eu-0100501
53. D04018
54. E 3250
55. Q27290771
56. Ephedrine Sulphate 1.0 Mg/ml In Methanol (as Free Base)
57. Bis((r-(r*,s*))-beta-hydroxy-alpha-methylphenethyl)methylammonium Sulphate
58. Bis((r-(r*,s*))-beta-hydroxy-alpha-methylphenethyl)methylammonium) Sulphate
59. Benzenemethanol, Alpha-((1s)-1-(methylamino)ethyl)-, (alphar)-, Sulfate (2:1)
60. Benzenemethanol, Alpha-(1-(methylamino)ethyl)-, (r-(r*,s*))-, Sulfate (2:1) (salt)
61. Benzenemethanol, Alpha-(1-(methylamino)ethyl)-, (theta-(theta,s))-, Sulfate (2:1) (salt)
62. (r-(r*,s*))-.alpha.-(1-(methylamino)ethyl)benzenemethanol Sulfate (2:1) (salt) [who-ip]
63. Benzenemethanol, .alpha.-(1-(methylamino)ethyl)-, (r-(r*,s*))-, Sulfate (2:1) (salt)
Molecular Weight | 428.5 g/mol |
---|---|
Molecular Formula | C20H32N2O6S |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 8 |
Rotatable Bond Count | 6 |
Exact Mass | 428.19810792 g/mol |
Monoisotopic Mass | 428.19810792 g/mol |
Topological Polar Surface Area | 148 Ų |
Heavy Atom Count | 29 |
Formal Charge | 0 |
Complexity | 202 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 4 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
Adrenergic Agents
Drugs that act on adrenergic receptors or affect the life cycle of adrenergic transmitters. Included here are adrenergic agonists and antagonists and agents that affect the synthesis, storage, uptake, metabolism, or release of adrenergic transmitters. (See all compounds classified as Adrenergic Agents.)
Sympathomimetics
Drugs that mimic the effects of stimulating postganglionic adrenergic sympathetic nerves. Included here are drugs that directly stimulate adrenergic receptors and drugs that act indirectly by provoking the release of adrenergic transmitters. (See all compounds classified as Sympathomimetics.)
Vasoconstrictor Agents
Drugs used to cause constriction of the blood vessels. (See all compounds classified as Vasoconstrictor Agents.)
Central Nervous System Stimulants
A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)
API/FDF Prices: Book a Demo to explore the features and consider upgrading later
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
DRUG PRODUCT COMPOSITIONS
Related Excipient Companies
Excipients by Applications
Market Place
Patents & EXCLUSIVITIES
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
94
PharmaCompass offers a list of Ephedrine Sulfate API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ephedrine Sulfate manufacturer or Ephedrine Sulfate supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ephedrine Sulfate manufacturer or Ephedrine Sulfate supplier.
PharmaCompass also assists you with knowing the Ephedrine Sulfate API Price utilized in the formulation of products. Ephedrine Sulfate API Price is not always fixed or binding as the Ephedrine Sulfate Price is obtained through a variety of data sources. The Ephedrine Sulfate Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A E 3250 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of E 3250, including repackagers and relabelers. The FDA regulates E 3250 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. E 3250 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of E 3250 manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A E 3250 supplier is an individual or a company that provides E 3250 active pharmaceutical ingredient (API) or E 3250 finished formulations upon request. The E 3250 suppliers may include E 3250 API manufacturers, exporters, distributors and traders.
click here to find a list of E 3250 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A E 3250 DMF (Drug Master File) is a document detailing the whole manufacturing process of E 3250 active pharmaceutical ingredient (API) in detail. Different forms of E 3250 DMFs exist exist since differing nations have different regulations, such as E 3250 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A E 3250 DMF submitted to regulatory agencies in the US is known as a USDMF. E 3250 USDMF includes data on E 3250's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The E 3250 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of E 3250 suppliers with USDMF on PharmaCompass.
A E 3250 written confirmation (E 3250 WC) is an official document issued by a regulatory agency to a E 3250 manufacturer, verifying that the manufacturing facility of a E 3250 active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting E 3250 APIs or E 3250 finished pharmaceutical products to another nation, regulatory agencies frequently require a E 3250 WC (written confirmation) as part of the regulatory process.
click here to find a list of E 3250 suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing E 3250 as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for E 3250 API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture E 3250 as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain E 3250 and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a E 3250 NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of E 3250 suppliers with NDC on PharmaCompass.
E 3250 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of E 3250 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right E 3250 GMP manufacturer or E 3250 GMP API supplier for your needs.
A E 3250 CoA (Certificate of Analysis) is a formal document that attests to E 3250's compliance with E 3250 specifications and serves as a tool for batch-level quality control.
E 3250 CoA mostly includes findings from lab analyses of a specific batch. For each E 3250 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
E 3250 may be tested according to a variety of international standards, such as European Pharmacopoeia (E 3250 EP), E 3250 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (E 3250 USP).